
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/O-PCE: Difference between revisions
Jump to navigation
Jump to search
>Kenan m Text replacement - "{{SubstanceBox <!-- Table Properties -->" to "{{SubstanceBox <!-- Special Parameters --> |displayClasses={{{displayClasses|}}}" |
>Unity Expanded |
||
Line 40: | Line 40: | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=O-PCE, 2'-Oxo-PCE | |NameCommon=O-PCE, Eticyclidone | ||
|NameSubstitution=2'-Oxo-PCE | |||
|NameSystematic=2-(ethylamino)-2-phenylcyclohexan-1-one | |NameSystematic=2-(ethylamino)-2-phenylcyclohexan-1-one | ||
Line 50: | Line 50: | ||
<!-- Dosage/Duration --> | <!-- Dosage/Duration --> | ||
|OralROA=true | |||
|OralROA_Collapsed=false | |||
|OralROA_Caption= | |||
|OralROA_Bioavailability= | |||
|OralROA_Threshold=[[Oral threshold dose::1]] - 3 [[Oral dose units::mg]] | |||
|OralROA_Light=[[Oral min light dose::3]] - [[Oral max light dose::6]] mg | |||
|OralROA_Common=[[Oral min common dose::6]] - [[Oral max common dose::12]] mg | |||
|OralROA_Strong=[[Oral min strong dose::12]] - [[Oral max strong dose::20]] mg | |||
|OralROA_Heavy=[[Oral min strong dose::20]] mg + | |||
|OralROA_TimelineFile= | |||
|OralROA_TimelineWidth= | |||
|OralROA_Duration=[[Oral min duration time::6]] - [[Oral max duration time::8]] [[Oral duration time units::hours]] | |||
|OralROA_Onset=[[Oral min onset time::30]] - [[Oral max onset time::90]] [[Oral onset time units::minutes]] | |||
|OralROA_Peak=[[Oral min peak time::3]] - [[Oral max peak time::4]] [[Oral peak time units::hours]] | |||
|OralROA_Offset=[[Oral min offset time::2]] - [[Oral max offset time::3]] [[Oral offset time units::minutes]] | |||
|OralROA_Aftereffects=[[Oral min afterglow time::8]] - [[Oral max offset time::48]] [[Oral offset time units::hours]] | |||
|InsufflatedROA=true | |InsufflatedROA=true | ||
|InsufflatedROA_Collapsed= | |InsufflatedROA_Collapsed=true | ||
|InsufflatedROA_Caption= | |InsufflatedROA_Caption= | ||
|InsufflatedROA_Bioavailability= | |InsufflatedROA_Bioavailability= | ||
Line 59: | Line 76: | ||
|InsufflatedROA_Common=[[Insufflated min common dose::6]] - [[Insufflated max common dose::12]] mg | |InsufflatedROA_Common=[[Insufflated min common dose::6]] - [[Insufflated max common dose::12]] mg | ||
|InsufflatedROA_Strong=[[Insufflated min strong dose::12]] - [[Insufflated max strong dose::20]] mg | |InsufflatedROA_Strong=[[Insufflated min strong dose::12]] - [[Insufflated max strong dose::20]] mg | ||
|InsufflatedROA_Heavy=20 mg + | |InsufflatedROA_Heavy=[[Insufflated min strong dose::20]] mg + | ||
|InsufflatedROA_TimelineFile= | |InsufflatedROA_TimelineFile= | ||
|InsufflatedROA_TimelineWidth= | |InsufflatedROA_TimelineWidth= | ||
|InsufflatedROA_Duration=4 - 6 hours | |InsufflatedROA_Duration=[[Insufflated min duration time::4]] - [[Insufflated max duration time::6]] [[Insufflated duration time units::hours]] | ||
|InsufflatedROA_Onset=[[Insufflated min onset time::30]] - [[Insufflated max onset time::60]] [[Insufflated onset time units::minutes]] | |InsufflatedROA_Onset=[[Insufflated min onset time::30]] - [[Insufflated max onset time::60]] [[Insufflated onset time units::minutes]] | ||
|InsufflatedROA_Peak=[[Insufflated min peak time:: | |InsufflatedROA_Peak=[[Insufflated min peak time::2]] - [[Insufflated max peak time::3]] [[Insufflated peak time units::hours]] | ||
|InsufflatedROA_Offset=[[Insufflated min offset time:: | |InsufflatedROA_Offset=[[Insufflated min offset time::1]] - [[Insufflated max offset time::2]] [[Insufflated offset time units::minutes]] | ||
|InsufflatedROA_Aftereffects= | |InsufflatedROA_Aftereffects=[[Insufflated min afterglow time::2]] - [[Insufflated max offset time::12]] [[Insufflated offset time units::hours]] | ||
}} | }} |
Revision as of 22:56, 25 March 2017
SubstanceBox/O-PCE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common names | O-PCE, Eticyclidone | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Substitutive name | 2'-Oxo-PCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Systematic name | 2-(ethylamino)-2-phenylcyclohexan-1-one | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|